Appclon recently ranked among the top searched stocks on 2 days within the past month.


As of 9:30 AM on the 14th, Appclon is trading at 37,950 KRW, down 2.44% from the previous day. This represents a 9.68% increase compared to August 19. Appclon is known as the only domestic bio new drug development specialist among listed companies.

Over the past 5 days, individual investors have net sold 24,272 shares, while foreigners and institutions have net bought 32,526 shares and 501 shares, respectively.


On September 10, Appclon became a market issue with headlines such as "Soaring with wings... COVID-19 treatment and blood cancer treatment..."



※Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing